Good morning :)
Niva Bupa Health Insurance Company Limited

Niva Bupa Health Insurance Company Limited

NIVABUPA Share Price

NSE
85.420.06% (-0.05)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹15,790 cr, stock is ranked 454

Stock is 1.75x as volatile as Nifty

NIVABUPA Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹15,790 cr, stock is ranked 454

Stock is 1.75x as volatile as Nifty

NIVABUPA Performance & Key Metrics

NIVABUPA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
90.624.17
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
16.762.171.24%

NIVABUPA Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
91%
Analysts have suggested that investors can buy this stock

from 11 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

NIVABUPA Company Profile

Niva Bupa Health Insurance, a standalone health insurer in India, specializes in health, personal accident, and travel insurance products for both retail and group customers.

Investor Presentation

View older View older 

Jul 30, 2026

PDF
View Older Presentations

NIVABUPA Similar Stocks (Peers)

Compare with peers Compare with peers 

NIVABUPA Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
8.94
8.94
1Y Return
10.41%
10.41%
Buy Reco %
82.61
82.61
PE Ratio
33.17
33.17
1Y Return
5.68%
5.68%
Buy Reco %
85.71
85.71
PE Ratio
74.63
74.63
1Y Return
0.72%
0.72%
Buy Reco %
97.14
97.14
PE Ratio
60.88
60.88
1Y Return
29.91%
29.91%
Buy Reco %
97.06
97.06
PE Ratio
29.62
29.62
1Y Return
13.58%
13.58%
Buy Reco %
52.17
52.17
Compare with Peers

NIVABUPA Sentiment Analysis

NIVABUPA Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

NIVABUPA Stock Summary · May 2026

The dominant message was robust top-line growth underpinned by retail momentum, tempered by underwriting mix and regulatory uncertainty. Management highlighted Gross Written Premium up 27.4% to INR 9,433 crore and profit after tax rising to INR 366 crore, and spoke with a pragmatic, execution-focused tone emphasizing cost discipline, distribution expansion and technology-led efficiency. They stressed three expense levers—shift to renewals, operating leverage from GWP growth, and analytics/AI investments—to drive further expense-ratio improvement, while continuing to scale agency, bancassurance, digital channels and a Bharat-focused push into smaller towns. At the same time they acknowledged underwriting pressure from mix and the need to manage commission policy risk as they await regulator guidance, and outlined a hospital-empanelment and protocol-standardization program to lower claim costs and enhance transparency. Near term, management said they will implement Ind AS/IFRS this quarter with full annexures, continue investing in multichannel reach and cost initiatives, and expect continued premium growth alongside gradual margin improvement as these actions take effect.

NIVABUPA Stock Growth Drivers
NIVABUPA Stock Growth Drivers
7
  • Marked improvement in financial performance and capital strength

    The company delivered materially stronger financial results across top-line, profitability and solvency metrics: gross written

  • Strong retail growth, expanding market share and improving unit economics

    Retail momentum is a clear strength: retail segment premium grew 35% for the year with

NIVABUPA Stock Challenges
NIVABUPA Stock Challenges
4
  • Regulatory pressure on distribution economics (commissions and bancassurance)

    Regulatory risk to the company's distribution economics is material and recurring: analysts explicitly asked how

  • Deteriorating underwriting performance and provisioning risk

    Underwriting metrics and IFRS provisioning show signs of stress: the IFRS net claims (loss) ratio

NIVABUPA Forecast

NIVABUPA Forecasts

Price

Revenue

Earnings

NIVABUPA

NIVABUPA

Income

Balance Sheet

Cash Flow

NIVABUPA Income Statement

NIVABUPA Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue1,372.191,208.691,399.871,294.921,626.211,931.601,591.971,617.602,250.162,470.77
Operating & Other expensessubtract1,215.131,227.511,386.851,281.681,420.131,833.681,627.241,705.242,069.422,287.03
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.000.00
Interest & Other Itemssubtract0.000.000.000.000.000.000.000.000.000.00
Taxes & Other Itemssubtract0.000.000.000.000.0026.480.000.0021.3845.94
EPS0.92-0.110.080.071.130.39-0.19-0.470.860.75

NIVABUPA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Jul 30PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 8PDF
Jan 29PDF
Nov 3PDF
Jul 31PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 7PDF
Feb 4PDF
Nov 25PDF
 

NIVABUPA Stock Peers

NIVABUPA Past Performance & Peer Comparison

NIVABUPA Past Performance & Peer Comparison

Comparing 3 stocks from 
FinancialsInsurance

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Niva Bupa Health Insurance Company Limited120.744.17
Life Insurance Corporation Of India8.942.901.23%
Bajaj Finserv Ltd33.172.310.07%
SBI Life Insurance Company Ltd74.639.660.15%

NIVABUPA Stock Price Comparison

Compare NIVABUPA with any stock or ETF
Compare NIVABUPA with any stock or ETF
NIVABUPA
Loading...

NIVABUPA Holdings

NIVABUPA Shareholdings

NIVABUPA Promoter Holdings Trend

NIVABUPA Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

NIVABUPA Institutional Holdings Trend

NIVABUPA Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 1.49%

Tickertape Separator

NIVABUPA Shareholding Pattern

NIVABUPA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding55.30%9.35%6.82%12.09%16.44%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

NIVABUPA Shareholding History

NIVABUPA Shareholding History

MarJunSepDec '25MarJun8.90%10.76%10.72%10.32%10.60%12.09%

Mutual Funds Invested in NIVABUPA

Mutual Funds Invested in NIVABUPA

No mutual funds holding trends are available

Top 5 Mutual Funds holding Niva Bupa Health Insurance Company Limited




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
2.7832%0.80%0.19%110/133 (-8)
1.4146%0.75%0.30%47/147 (+29)
0.9286%0.75%-0.05%48/86 (+15)

Compare 3-month MF holding change on Screener

NIVABUPA Insider Trades & Bulk Stock Deals

NIVABUPA Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing NIVABUPA stock

smallcases containing NIVABUPA stock

Looks like this stock is not in any smallcase yet.

NIVABUPA Events

NIVABUPA Events

NIVABUPA Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

NIVABUPA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

NIVABUPA Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

NIVABUPA has not given any dividends in last 5 years

NIVABUPA Dividends

NIVABUPA Dividends

Hmm, looks like data is unavailable here. Please come back after some time

NIVABUPA Stock News & Opinions

NIVABUPA Stock News & Opinions

Earnings
Earnings
Niva Bupa Health Insurance Company reports standalone net profit of Rs 137.80 crore in the June 2026 quarter

Net profit of Niva Bupa Health Insurance Company reported to Rs 137.80 crore in the quarter ended June 2026 as against net loss of Rs 91.44 crore during the previous quarter ended June 2025. Sales reported to Rs -2273.72 crore in the quarter ended June 2026 as against Rs 1220.00 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales-2273.721220.00 PL OPM %-8.10-7.62 - PBDT183.74-91.44 LP PBT183.74-91.44 LP NP137.80-91.44 LP Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Corporate
Niva Bupa Health Insurance reports Rs 138 crore PAT, a 93% year-on-year increase

Niva Bupa Health Insurance Company Limited reported a Profit After Tax (PAT) of Rs 138 crore for the quarter ended June 30, 2026, a 93% year-on-year increase, according to a press release issued on Wednesday. The company’s Gross Written Premium (GWP) rose 32% to Rs 2,150 crore, while its retail health business grew 47%, increasing its Retail Health Market Share to 11.1%. Niva Bupa’s Claim Settlement Ratio improved to 95.6% and the Combined Insurance Service Ratio (CISR) improved to 100.2% from 103.2% in the previous year.

1 week agoCapital Market - Live
Corporate
Corporate
Niva Bupa Health Insurance Company schedules board meeting

Niva Bupa Health Insurance Company will hold a meeting of the Board of Directors of the Company on 30 July 2026.

2 weeks agoCapital Market - Live
Corporate
Corporate
Niva Bupa Health Insurance Company to convene AGM

Niva Bupa Health Insurance Company announced that the 18th Annual General Meeting(AGM) of the company will be held on 12 August 2026.

3 weeks agoCapital Market - Live
Corporate
Corporate
Niva Bupa Health Insurance Company allots 14.76 lakh equity shares under ESOP

Niva Bupa Health Insurance Company has allotted 14,76,432 equity shares under ESOP on 23 June 2026. Consequent to the aforesaid allotment, the paid-up equity share capital of the Company stands increased to Rs 18,49,23,37,030/- comprising 1,84,92,33,703 equity shares of face value of Rs 10/- each.

1 month agoCapital Market - Live
Spotlight
Spotlight
Volumes soar at Niva Bupa Health Insurance Company Ltd counter

Marico Ltd, AAVAS Financiers Ltd, Blue Jet Healthcare Ltd, Cohance Lifesciences Ltd are among the other stocks to see a surge in volumes on BSE today, 11 June 2026.Niva Bupa Health Insurance Company Ltd recorded volume of 41.42 lakh shares by 10:46 IST on BSE, a 39.73 times surge over two-week average daily volume of 1.04 lakh shares. The stock gained 0.24% to Rs.84.39. Volumes stood at 1.16 lakh shares in the last session.Marico Ltd notched up volume of 5.74 lakh shares by 10:46 IST on BSE, a 13.5 fold spurt over two-week average daily volume of 42508 shares. The stock slipped 0.07% to Rs.819.35. Volumes stood at 89547 shares in the last session.AAVAS Financiers Ltd notched up volume of 6.12 lakh shares by 10:46 IST on BSE, a 7.71 fold spurt over two-week average daily volume of 79379 shares. The stock rose 1.81% to Rs.1,322.00. Volumes stood at 1.12 lakh shares in the last session.Blue Jet Healthcare Ltd saw volume of 1.59 lakh shares by 10:46 IST on BSE, a 7.5 fold spurt over two-week average daily volume of 21166 shares. The stock increased 8.38% to Rs.509.05. Volumes stood at 27050 shares in the last session.Cohance Lifesciences Ltd registered volume of 3.49 lakh shares by 10:46 IST on BSE, a 6.1 fold spurt over two-week average daily volume of 57243 shares. The stock slipped 1.36% to Rs.425.15. Volumes stood at 37906 shares in the last session.Powered by Capital Market - Live

2 months agoCapital Market - Live
Spotlight
Spotlight
Niva Bupa appoints Ashwani Bhatia as Chairperson; Milind Barve steps down

The company's board has also approved Bhatia's appointment as an Additional Director in the capacity of Non-Executive Independent Director for a term of five consecutive years, subject to shareholders' approval. Meanwhile, Milind Gajanan Barve has resigned as Non-Executive Independent Director and Chairman of the Board, effective from the close of business hours on June 2, 2026, citing persistent health issues. Barve stated that there were no material reasons for his resignation other than those disclosed in his resignation letter. Niva Bupa Health Insurance Company is a leading standalone health insurers in India. As of 31 March 2025, Niva Bupa has over 212 physical branches across India. It additionally offers health insurance through its ecosystem partners including 1.8+ lakh agents, 540 brokers, and over 100 banca & other corporate agency partners. The company's standalone net profit rose 31.21% to Rs 206.08 crore while total income rose 18.51% to Rs 1,626.21 crore in Q4 FY25 over Q4 FY24. Shares of Niva Bupa Health Insurance shed 0.73% to Rs 83.36 on the BSE. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Corporate
Niva Bupa Health Insurance Company appoints Ashwani Bhatia as Chairperson

Niva Bupa Health Insurance Company has appointed Ashwani Bhatia (DIN: 07423221) as an Additional Director in the category of Non-Executive, Independent Director, for a term of five (5) consecutive years with effect from 03 June 2026, subject to approval of the shareholders. Simultaneously, the Board has also approved the appointment of Ashwani Bhatia as Chairperson of the Board effective 03 June 2026.

2 months agoCapital Market - Live
Corporate
Corporate
Niva Bupa Health Insurance Company director resigns

Niva Bupa Health Insurance Company announced the resignation of Milind Gajanan Barve (DIN: 00087839), Non-Executive, Independent Director with effect from 02 June 2026.

2 months agoCapital Market - Live
Earnings
Earnings
Niva Bupa Health Insurance Company standalone net profit rises 67.47% in the March 2026 quarter

Net profit of Niva Bupa Health Insurance Company rose 67.47% to Rs 345.13 crore in the quarter ended March 2026 as against Rs 206.08 crore during the previous quarter ended March 2025. Sales rose 29.10% to Rs 1971.95 crore in the quarter ended March 2026 as against Rs 1527.42 crore during the previous quarter ended March 2025. For the full year,net profit declined 38.75% to Rs 130.78 crore in the year ended March 2026 as against Rs 213.52 crore during the previous year ended March 2025. Sales rose 23.97% to Rs 6067.57 crore in the year ended March 2026 as against Rs 4894.46 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1971.951527.42 29 6067.574894.46 24 OPM %18.5216.41 -2.061.19 - PBDT341.16206.08 66 126.81213.52 -41 PBT341.16206.08 66 126.81213.52 -41 NP345.13206.08 67 130.78213.52 -39 Powered by Capital Market - Live

3 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Niva Bupa Health Insurance Company Limited (NIVABUPA) today?

    The share price of NIVABUPA as on 12th August 2026 is ₹85.42. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Niva Bupa Health Insurance Company Limited (NIVABUPA) share?

    The past returns of Niva Bupa Health Insurance Company Limited (NIVABUPA) share are
    • Past 1 week: -1.45%
    • Past 1 month: -1.29%
    • Past 3 months: 1.38%
    • Past 6 months: 10.23%
    • Past 1 year: 7.31%
    • Past 3 years: N/A%
    • Past 5 years: 15.47%

  3. What are the peers or stocks similar to Niva Bupa Health Insurance Company Limited (NIVABUPA)?
  4. What is the market cap of Niva Bupa Health Insurance Company Limited (NIVABUPA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Niva Bupa Health Insurance Company Limited (NIVABUPA) is ₹15790.21 Cr as of 12th August 2026.

  5. What is the 52 week high and low of Niva Bupa Health Insurance Company Limited (NIVABUPA) share?

    The 52-week high of Niva Bupa Health Insurance Company Limited (NIVABUPA) is ₹91.40 and the 52-week low is ₹67.50.

  6. What is the PE and PB ratio of Niva Bupa Health Insurance Company Limited (NIVABUPA) stock?

    The P/E (price-to-earnings) ratio of Niva Bupa Health Insurance Company Limited (NIVABUPA) is 120.74. The P/B (price-to-book) ratio is 4.17.

  7. Which sector does Niva Bupa Health Insurance Company Limited (NIVABUPA) belong to?

    Niva Bupa Health Insurance Company Limited (NIVABUPA) belongs to the Financials sector & Insurance sub-sector.

  8. How to buy Niva Bupa Health Insurance Company Limited (NIVABUPA) shares?

    You can directly buy Niva Bupa Health Insurance Company Limited (NIVABUPA) shares on Tickertape. Simply sign up, connect your demat account and place your order.